4//SEC Filing
Adamis Pharmaceuticals Corp 4
Accession 0001144204-13-041009
CIK 0000887247operating
Filed
Jul 23, 8:00 PM ET
Accepted
Jul 24, 7:58 PM ET
Size
17.2 KB
Accession
0001144204-13-041009
Insider Transaction Report
Form 4
Rahman Ahmed Shayan Fazlur
10% Owner
Transactions
- Sale
Common Stock, par value $0.0001
2013-07-22$0.60/sh−20,000$12,012→ 29,955,067 total(indirect: See Footnote) - Sale
Common Stock, par value $0.0001
2013-07-22$0.60/sh−5,000$3,000→ 29,950,067 total(indirect: See Footnote) - Sale
Common Stock, par value $0.0001
2013-07-23$0.59/sh−24,900$14,691→ 29,833,843 total(indirect: See Footnote) - Sale
Common Stock, par value $0.0001
2013-07-22$0.56/sh−10,000$5,601→ 29,940,067 total(indirect: See Footnote) - Sale
Common Stock, par value $0.0001
2013-07-23$0.56/sh−66,000$36,960→ 29,863,743 total(indirect: See Footnote) - Sale
Common Stock, par value $0.0001
2013-07-23$0.58/sh−5,000$2,900→ 29,858,743 total(indirect: See Footnote) - Sale
Common Stock, par value $0.0001
2013-07-22$0.56/sh−10,324$5,781→ 29,929,743 total(indirect: See Footnote)
Footnotes (1)
- [F1]Represents shares of the Issuer's common stock held by Eses Holdings (FZE), a corporation organized under the laws of Sharjah, United Arab Emirates ("Eses"). Ahmed Shayan Fazlur Rahman is the sole shareholder of Eses, and possesses the power to vote and the power to direct the disposition of all securities of the Issuer held by Eses.
Documents
Issuer
Adamis Pharmaceuticals Corp
CIK 0000887247
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000887247
Filing Metadata
- Form type
- 4
- Filed
- Jul 23, 8:00 PM ET
- Accepted
- Jul 24, 7:58 PM ET
- Size
- 17.2 KB